Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy

Journal of Clinical Laboratory Analysis

Volumn 17, Issue 2, 2003, Pages 66-72

  Borba, R ^a   Lima, C S P ^a   Grotto, H Z W ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

F cells; Hydroxyurea; Reticulocyte immaturity; Sickle cell anemia

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ERYTHROPOIESIS; FLUORESCENCE; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; HEMOLYSIS; HUMAN; HUMAN CELL; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; RETICULOCYTE; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; FETAL HEMOGLOBIN; HUMANS; HYDROXYUREA; NEUTROPHILS; REFERENCE VALUES; RETICULOCYTE COUNT; RETICULOCYTES;

MURAYAMA VIRUS;

EID: 0038078994     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.10070     Document Type: Article

References (37)

1. Goldberg MA, Husson MA, Bunn HF. 1977. The participation of hemoglobins A and F in the polymerization of sickle hemoglobin. J Biol Chem 252:3414-3421.
2. Yarbro JW. 1992. Mechanism of action of hydroxyurea. Semin Oncol 19:1-10.
3. Charache S, Dover GJ, Moore RD, et al. 1992. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555-2565.
4. Lima CSP, Arruda VR, Costa FF, Saad STO. 1997. Minimal doses of hydroxyurea for sickle cell disease. Brazil J Med Biol Res 30:933-940.
5. Blau C, Constantoulakis P, Al-Khatti A, et al. 1993. Fetal hemoglobin in acute and chronic states of erythroid expansion. Blood 81:227-233.
6. Nagel RL, Vichhinsky E, Shah M, et al. 1993. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood 81:9-14.
7. Steinberg MH, Nagel RL, Brugnara C. 1997. Cellular effects of hydroxyurea in Hb SC disease. Br J Haematol 98:838-844.
8. Brugnara C. 1998. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 28:1-11.
9. Tsuda I, Tatsumi N. 1989. Maturity of reticulocytes in various hematological disorders. Eur J Haematol 43:252-254.
10. D'Onofrio G, Tichelli A, Foures C, Theodorsen L. 1996. Indicators of haematopoietic recovery after bone marrow transplantation: the role of reticulocyte measurements. Clin Lab Haematol 18:45-53.
11. Cavill I. 1993. Annotation. The rejected reticulocyte. Br J Haematol 84:563-565.
12. Davies SV, Cavill I, Bentley N, Fegan CD, Poyton CH, Whittaker JA. 1992. Evaluation of erythropoiesis after bone marrow transplantation: quantitative reticulocyte counting. Br J Haematol 81:12-17.
13. Grotto HZW, Vigoritto AC, Noronha JFA, Lima GALM. 1999. Immature reticulocyte fraction as a criterion for marrow engraftment. Evaluation of a semi-automated reticulocyte counting method. Clin Lab Haematol 21:285-287.
14. Dacie JV, Lewis SM, editors. 1995. Practical hematology. Edinburgh: Churchill Livingstone. p 240-286.
15. Weatherall DJ, Clegg JB, editors. 1972. The thalassemia syndrome. Oxford: Blackwell Scientific Publishing. p 744-769.
16. Pembrey ME, MacWade P, Weatherall DJ. 1972. Reliable routine estimation of small amounts of foetal hemoglobin by alkali denaturation. J Clin Pathol 25:738-740.
17. Marcus SJ, Ware RE. 1999. Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention. J Pediatr Hematol Oncol 21:407-411.
18. Rodgers GP. 1997. Overview of pathophysiology and rationale for treatment of sickle cell anemia. Semin Hematol 34:2-7.
19. Pearson HA. 1996. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality. Adv Pediatr 43:309-334.
20. Olivieri NF, Weatherall DJ. 1998. The therapeutic reactivation of fetal hemoglobin. Hum Mol Genet 7:1655-1658.
21. Brugnara C, Zelmanovic D, Sorette M, Ballas SK, Platt O. 1997. Reticulocyte hemoglobin. An integrated parameter for evaluation of erythropoietic activity. Am J Clin Pathol 108:133-142.
22. Torres A, Sanchez J, Lakomsky D, et al. 2001. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation. Haematologica 86:24-29.
23. Chang C-C, Kass L. 1997. Clinical significance of immature reticulocyte fraction determined by automated reticulocyte counting. Am J Clin Pathol 108:69-73.
24. Grotto HZW, Noronha JFA. 2000. Evaluation of reticulocyte counting using the Pentra 120 Retic automated haematology analyzer: clinical application of mean fluorescence index (MFI) in bone marrow transplantation. J Bras Patol 36:234-240.
25. Ballas SK, Dover GJ, Charache S. 1989. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo. Am J Hematol 32:104-111.
26. Ballas SK, Marcolina MJ, Dover GJ, Barton FB, Investigators of the Multicenter Study of Hydroxyurea Sickle Cell Anemia. 1999. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea. Br J Haematol 105:491-496.
27. Ohene-Frempong K, Smith-Whitley K. 1997. Use of hydroxyurea in children with sickle cell disease: what comes next? Semin Hematol 34:30-41.
28. Milner PF, Garbutt GJ, Nolan-Davis LV, Jonah F, Wilson LB, Wilson JT. 1986. The effect of HbF and alpha-thalassemia on the red cell indices in sickle-cell anemia. Am J Hematol 21:383-395.
29. Miller MK, Zimmerman SA, Schultz WH, Ware RE. 2001. Hydroxyurea therapy for pediatric patients with hemoglobin SC disease. J Pediatr Hematol Oncol 23:306-308.
30. Dover GJ, Boyer SH, Charache S, Heintzelman K. 1978. Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med 299:1428-1435.
31. Maier-Redelsperger M, Elion J, Girot R. 1998. F reticulocytes assay: a method to evaluate fetal hemoglobin production. Hemoglobin 22:419-425.
32. Wood WG, Stamatoyannopoulos G, Lim G, Nute PE. 1975. F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of HbF. Blood 46:671-682.
33. Marcus ST, Kinney TR, Schultz WH, O'Branski EE, Ware RE. 1997. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease. Am J Hematol 54:40-46.
34. Dover GG, Charache S. 1992. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease. Semin Oncol 19:61-66.
35. Maier-Redelsperger M, Noguchi CT, de Montalembert M, et al. 1994. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian prospective study on sickle cell disease. Blood 84:3182-3188.
36. Bridges KR, Barabino GD, Brugnara C, et al. 1996. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 88:4701-4710.
37. Charache S. 1997. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol 34:15-21.